Alexander N Shoushtari Selected Research

Alexander N Shoushtari Research Topics

Disease

54	Melanoma (Melanoma, Malignant) 05/2024 - 12/2014
36	Neoplasms (Cancer) 05/2024 - 01/2007
22	Uveal melanoma 06/2024 - 12/2014
7	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2017
6	Disease Progression 11/2023 - 01/2018
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2014
3	Exanthema (Rash) 12/2023 - 01/2018
2	Pruritus (Itching) 12/2023 - 01/2021
2	Fever (Fevers) 12/2023 - 01/2021
2	Brain Neoplasms (Brain Tumor) 01/2020 - 12/2019
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 06/2017
2	Edema (Dropsy) 01/2019 - 01/2018
2	Carcinogenesis 09/2017 - 01/2016
1	Hypotension (Low Blood Pressure) 12/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Bites and Stings (Sting) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Rupture 01/2021
1	Chromosomal Instability (Chromosome Stability) 01/2021
1	Paralysis (Palsy) 06/2020
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 06/2020
1	Diplopia (Double Vision) 06/2020
1	Myocarditis (Carditis) 01/2019
1	Anemia 01/2019
1	Hyperphosphatemia 01/2019
1	Myocardial Infarction 01/2019

Drug/Important Bio-Agent (IBA)

21	IpilimumabIBA 06/2024 - 01/2015
17	NivolumabIBA 06/2024 - 11/2016
15	Immune Checkpoint InhibitorsIBA 06/2024 - 01/2019
8	pembrolizumabIBA 12/2023 - 11/2016
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2017
5	DNA (Deoxyribonucleic Acid)IBA 06/2024 - 01/2020
5	tebentafuspIBA 12/2023 - 11/2020
4	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2018
3	CytokinesIBA 05/2024 - 11/2020
3	Dacarbazine (DIC)FDA LinkGeneric 12/2023 - 01/2018
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 01/2021
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 11/2020
3	CTLA-4 AntigenIBA 01/2023 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2014
3	AntibodiesIBA 09/2017 - 11/2016
2	Circulating Tumor DNAIBA 06/2024 - 11/2021
2	HLA-A Antigens (HLA-A)IBA 12/2023 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 12/2023 - 01/2021
2	relatlimabIBA 03/2023 - 11/2022
2	B7-H1 AntigenIBA 01/2023 - 03/2015
2	Imatinib Mesylate (Gleevec)FDA Link 11/2022 - 01/2019
2	LigandsIBA 01/2022 - 11/2016
2	sotrastaurinIBA 11/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2009
2	Blocking AntibodiesIBA 01/2021 - 01/2021
2	Protein Kinase CIBA 01/2020 - 12/2014
2	Lipase (Acid Lipase)FDA Link 01/2019 - 01/2017
2	Monoclonal AntibodiesIBA 04/2016 - 01/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016 - 12/2014
1	Cell-Free Nucleic AcidsIBA 06/2024
1	MART-1 AntigenIBA 01/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	durvalumabIBA 01/2023
1	tremelimumabIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Immunoconjugates (Immunoconjugate)IBA 06/2022
1	Melphalan (Alkeran)FDA LinkGeneric 06/2022
1	Bevacizumab (Avastin)FDA Link 06/2022
1	Arginine (L-Arginine)FDA Link 05/2022
1	PerforinIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	CrizotinibIBA 01/2022
1	utomilumabIBA 01/2022
1	AlpelisibIBA 11/2021
1	GlucocorticoidsIBA 11/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	YM-254890IBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Polycomb Repressive Complex 1IBA 01/2021
1	AntigensIBA 11/2020
1	erdafitinibIBA 10/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 10/2020
1	SteroidsIBA 06/2020
1	toripalimabIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2019
1	infigratinibIBA 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	Ado-Trastuzumab EmtansineIBA 12/2018

Therapy/Procedure

35	Therapeutics 12/2023 - 01/2007
19	Immunotherapy 10/2023 - 01/2015
4	Radiotherapy 05/2020 - 01/2016
3	Aftercare (After-Treatment) 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 03/2023 - 01/2014
2	Time-to-Treatment 01/2020 - 01/2018
1	Salvage Therapy 11/2023
1	Brachytherapy 01/2022
1	HAD protocol 01/2022
1	Precision Medicine 10/2020
1	Telescopes 06/2020
1	Metastasectomy 04/2020
1	Retreatment 01/2020